Diabetic autonomic imbalance and glycemic variability

Journal of Diabetes Science and Technology

Volumn 6, Issue 5, 2012, Pages 1207-1215

  Fleischer, Jesper ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Autonomic imbalance; Complications; Correlation between estimates of blood glucose variability; Diabetes; Glycemic variability; Heart rate variability; Hypothalamic pituitary adrenal axis; Neuropathy

Indexed keywords

CYTOKINE; GLUCOSE; HEMOGLOBIN A1C;

AUTONOMIC NERVOUS SYSTEM; AUTONOMIC NEUROPATHY; BRAIN BLOOD FLOW; CARDIOVASCULAR REFLEX; CARDIOVASCULAR RISK; CARDIOVASCULAR SYMPTOM; CHEMORECEPTOR REFLEX; CLINICAL FEATURE; DIABETES MELLITUS; DIABETIC AUTONOMIC NEURAL IMBALANCE; DIABETIC AUTONOMIC NEUROPATHY; DIABETIC NEUROPATHY; DIABETIC PATIENT; DIARRHEA; DISEASE ASSOCIATION; GLUCOSE TOLERANCE; GLYCEMIC CONTROL; GLYCEMIC VARIABILITY; HEART RATE VARIABILITY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MICTURITION DISORDER; NAUSEA; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; ORTHOSTATIC HYPOTENSION; OXIDATIVE STRESS; PRESSORECEPTOR REFLEX; PREVALENCE; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEXUAL DYSFUNCTION; STOMACH PARESIS; VOMITING; BLOOD; GLUCOSE BLOOD LEVEL; HEART RATE; METABOLISM; OBSERVER VARIATION; PATHOPHYSIOLOGY; PHYSIOLOGY;

AUTONOMIC NERVOUS SYSTEM DISEASES; BLOOD GLUCOSE; DIABETES MELLITUS; DIABETIC NEUROPATHIES; HEART RATE; HUMANS; OBSERVER VARIATION; PREVALENCE;

EID: 84875809806     PISSN: None     EISSN: 19322968     Source Type: Journal    
DOI: 10.1177/193229681200600526     Document Type: Review

References (87)

1. Vinik AI, Maser RE, Mitchell BD, Freeman R. Diabetic autonomic neuropathy. Diabetes Care. 2003;26(5):1553-79. (Pubitemid 36934465)
2. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group. BMJ. 1998;317(7160):703-13.
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N Engl J Med. 1993;329(14):977-86.
4. Pop-Busui R. Cardiac autonomic neuropathy in diabetes: a clinical perspective. Diabetes Care. 2010;33(2):434-41.
5. Ziegler D. Diabetic cardiovascular autonomic neuropathy: prognosis, diagnosis and treatment. Diabetes Metab Rev. 1994;10(4):339-83.
6. Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, Quagliaro L, Ceriello A, Giugliano D. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106(16):2067-72. (Pubitemid 35192812)
7. Bragd J, Adamson U, Bäcklund LB, Lins PE, Moberg E, Oskarsson P. Can glycaemic variability, as calculated from blood glucose self-monitoring, predict the development of complications in type 1 diabetes over a decade? Diabetes Metab. 2008;34 (6 Pt 1):612-6. Epub 2008 Sep 27.
8. Tesfaye S, Boulton AJ, Dyck PJ, Freeman R, Horowitz M, Kempler P, Lauria G, Malik RA, Spallone V, Vinik A, Bernardi L, Valensi P; Toronto Diabetic Neuropathy Expert Group. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care. 2010;33(10):2285-93.
9. Valensi P, Pariès J, Attali JR; French Group for Research and Study of Diabetic Neuropathy. Cardiac autonomic neuropathy in diabetic patients: influence of diabetes duration, obesity, and microangiopathic complications - the French multicenter study. Metabolism. 2003;52(7):815-20. (Pubitemid 36949541)
10. Ewing DJ, Martyn CN, Young RJ, Clarke BF. The value of cardiovascular autonomic function tests: 10 years experience in diabetes. Diabetes Care. 1985;8(5):491-8. (Pubitemid 15240914)
11. Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, Stevens M, Kempler P, Hilsted J, Tesfaye S, Low P, Valensi P; on behalf of the Toronto Consensus Panel on Diabetic Neuropathy*. Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev. 2011. doi: 10.1002/dmrr.1239. [Epub ahead of print]
12. Fleischer J, Yderstraede K, Gulichsen E, Jakobsen PE, Lervang H, Eldrup E, Nygaard H, Tarnow L, Ejskjaer N. Assessment of subclinical diabetic autonomic neuropathy in outpatient clinics using a point-of-care device: The DAN-study (Abstract). J Diabetes Sci Technol. 2012;6(2):A46.
13. Mazzeo AT, La Monaca E, Di Leo R, Vita G, Santamaria LB. Heart rate variability: a diagnostic and prognostic tool in anesthesia and intensive care. Acta Anaesthesiol Scand. 2011;55(7):797-811. doi: 10.1111/j.1399-6576.2011. 02466.x. Epub 2011 Jun 9.
14. Vinik AI, Ziegler D. Diabetic cardiovascular autonomic neuropathy. Circulation. 2007;115(3):387-97. (Pubitemid 46148513)
15. Vinik AI, Erbas T. Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med. 2001;68(11):928-30, 932, 934-44.
16. Spallone V, Bellavere F, Scionti L, Maule S, Quadri R, Bax G, Melga P, Viviani GL, Esposito K, Morganti R, Cortelli P; Diabetic Neuropathy Study Group of the Italian Society of Diabetology. Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. Nutr Metab Cardiovasc Dis. 2011;21(1):69-78.
17. Vinik AI, Erbas T. Cardiovascular autonomic neuropathy: diagnosis and management. Curr Diab Rep. 2006;6(6):424-30. (Pubitemid 44896401)
18. Vinik AI, Maser RE, Ziegler D. Autonomic imbalance: prophet of doom or scope for hope? Diabet Med. 2011;28(6):643-51. doi: 10.1111/j.1464-5491.2010. 03184.x.
19. Ceriello A, Ihnat MA. 'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting. Diabet Med. 2010;27(8):862-7.
20. Brownlee M, Hirsch IB. Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications. JAMA. 2006;295(14):1707-8.
21. Hirsch IB. Glycemic variability: it's not just about A1C anymore! Diabetes Technol Ther. 2005;7(5):780-3. (Pubitemid 41572082)
22. Monnier L, Colette C. Glycemic variability: should we and can we prevent it? Diabetes Care. 2008;31 Suppl 2:S150-4.
23. Kilpatrick ES, Rigby AS, Atkin SL. For debate. Glucose variability and diabetes complication risk: we need to know the answer. Diabet Med. 2010;27(8):868-71.
24. Kilpatrick ES. Arguments for and against the role of glucose variability in the development of diabetes complications. J Diabetes Sci Technol. 2009;3(4):649-55.
25. Monnier L, Colette C, Owens DR. Glycemic variability: the third component of the dysglycemia in diabetes. Is it important? How to measure it? J Diabetes Sci Technol. 2008;2(6):1094-100.
26. Eslami S, Taherzadeh Z, Schultz MJ, Abu-Hanna A. Glucose variability measures and their effect on mortality: a systematic review. Intensive Care Med. 2011;37(4):583-93. Epub 2011 Jan 29.
27. Egi M, Bellomo R. Reducing glycemic variability in intensive care unit patients: a new therapeutic target? J Diabetes Sci Technol. 2009;3(6):1302-8.
28. Di Flaviani A, Picconi F, Di Stefano P, Giordani I, Malandrucco I, Maggio P, Palazzo P, Sgreccia F, Peraldo C, Farina F, Frajese G, Frontoni S. Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients. Diabetes Care. 2011;34(7):1605-9. Epub 2011 May 24.
29. Su G, Mi S, Tao H, Li Z, Yang H, Zheng H, Zhou Y, Ma C. Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes. Cardiovasc Diabetol. 2011;10:19.
30. Ohlsson B, Melander O, Thorsson O, Olsson R, Ekberg O, Sundkvist G. Oesophageal dysmotility, delayed gastric emptying and autonomic neuropathy correlate to disturbed glucose homeostasis. Diabetologia. 2006;49(9):2010-4. Epub 2006 Jul 11.
31. Jamali R, Mohseni S. Differential neuropathies in hyperglycemic and hypoglycemic diabetic rats. J Neuropathol Exp Neurol. 2006;65(12):1118-25. (Pubitemid 44885936)
32. Monnier L, Mas E, Ginet C, Michel F, Villon L, Cristol JP, Colette C. Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes. JAMA. 2006;295(14):1681-7.
33. Chiodini I, Di Lembo S, Morelli V, Epaminonda P, Coletti F, Masserini B, Scillitani A, Arosio M, Adda G. Hypothalamic-pituitary-adrenal activity in type 2 diabetes mellitus: role of autonomic imbalance. Metabolism. 2006;55(8):1135-40. (Pubitemid 44043144)
34. Tsigos C, Young RJ, White A. Diabetic neuropathy is associated with increased activity of the hypothalamic-pituitary-adrenal axis. J Clin Endocrinol Metab. 1993;76(3):554-8. (Pubitemid 23086465)
35. Chiodini I, Adda G, Scillitani A, Coletti F, Morelli V, Di Lembo S, Epaminonda P, Masserini B, Beck-Peccoz P, Orsi E, Ambrosi B, Arosio M. Cortisol secretion in patients with type 2 diabetes: relationship with chronic complications. Diabetes Care. 2007;30(1):83-8. (Pubitemid 46052503)
36. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychosom Res. 2002;53(4):865-71. (Pubitemid 35282615)
37. Rutters F, Nieuwenhuizen AG, Lemmens SG, Born JM, Westerterp-Plantenga MS. Hypothalamic-pituitary-adrenal (HPA) axis functioning in relation to body fat distribution. Clin Endocrinol (Oxf). 2010;72(6):738-43. Epub 2009 Sep 21.
38. Rausch JR. Measures of glycemic variability and links with psychological functioning. Curr Diab Rep. 2010;10(6):415-21.
39. Whitsel EA, Raghunathan TE, Pearce RM, Lin D, Rautaharju PM, Lemaitre R, Siscovick DS. RR interval variation, the QT interval index and risk of primary cardiac arrest among patients without clinically recognized heart disease. Eur Heart J. 2001;22(2):165-73. (Pubitemid 32619638)
40. Dekker JM, Crow RS, Folsom AR, Hannan PJ, Liao D, Swenne CA, Schouten EG. Low heart rate variability in a 2-minute rhythm strip predicts risk of coronary heart disease and mortality from several causes: the ARIC Study. Atherosclerosis Risk In Communities. Circulation. 2000;102(11):1239-44.
41. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996;17(3):354-81.
42. Dekker JM, Schouten EG, Klootwijk P, Pool J, Swenne CA, Kromhout D. Heart rate variability from short electrocardiographic recordings predicts mortality from all causes in middle-aged and elderly men. The Zutphen Study. Am J Epidemiol. 1997;145(10):899-908. (Pubitemid 27200776)
43. Engel G, Beckerman JG, Froelicher VF, Yamazaki T, Chen HA, Richardson K, McAuley RJ, Ashley EA, Chun S, Wang PJ. Electrocardiographic arrhythmia risk testing. Curr Probl Cardiol. 2004;29(7):365-432.
44. DeBoer RW, Karemaker JM, Strackee J. Comparing spectra of a series of point events particularly for heart rate variability data. IEEE Trans Biomed Eng. 1984;31(4):384-7.
45. Freeman R. Assessment of cardiovascular autonomic function. Clin Neurophysiol. 2006;117(4):716-30. Epub 2006 Feb 7.
46. Kristiansen NK, Fleischer J, Jensen MS, Andersen KS, Nygaard H. Design and evaluation of a handheld impedance plethysmograph for measuring heart rate variability. Med Biol Eng Comput. 2005;43(4):516-21. (Pubitemid 41613336)
47. Fleischer J, Charles M, Tarnow L, Jensen KS, Nygaard H, Sandbaek A, Ejskjaer N. Paper electrocardiograph strips may contain overlooked clinical information in screen-detected type 2 diabetes patients. J Diabetes Sci Technol. 2012;6(1):74-80.
48. Mølgaard H, Sørensen KE, Bjerregaard P. Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death. Clin Auton Res. 1991;1(3):233-7.
49. Sharpey-Schafer EP, Taylor PJ. Absent circulatory reflexes in diabetic neuritis. Lancet. 1960;1(7124):559-62.
50. Wheeler T, Watkins PJ. Cardiac denervation in diabetes. Br Med J. 1973;4(5892):584-6.
51. Ewing DJ, Campbell IW, Murray A, Neilson JM, Clarke BF. Immediate heart-rate response to standing: simple test for autonomic neuropathy in diabetes. Br Med J. 1978;1(6106):145-7. (Pubitemid 8320452)
52. Hilsted J. Autonomic neuropathy: the diagnosis. Acta Neurol Scand. 1983;67(4):193-201. (Pubitemid 13115257)
53. Assessment: Clinical autonomic testing report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 1996;46(3):873-80.
54. Fleischer J, Nielsen R, Laugesen E, Nygaard H, Poulsen PL, Ejskjaer N. Self-monitoring of cardiac autonomic function at home is feasible. J Diabetes Sci Technol. 2011;5(1):107-12.
55. Fleischer J, Nygaard H, Ejskjaer N. Testing for autonomic neuropathy may support the diagnosis of diabetic gastroparesis (Abstract). J Diabetes Sci Technol. 2011;5(4):A9.
56. May O, Arildsen H. Long-term predictive power of heart rate variability on all-cause mortality in the diabetic population. Acta Diabetol. 2011;48(1):55-9. Epub 2010 Sep 16.
57. Takalo R, Korhonen I, Majahalme S, Tuomisto M, Turjanmaa V. Circadian profile of low-frequency oscillations in blood pressure and heart rate in hypertension. Am J Hypertens. 1999;12(9 Pt 1):874-81. (Pubitemid 29469940)
58. Singh JP, Larson MG, Tsuji H, Evans JC, O'Donnell CJ, Levy D. Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. Hypertension. 1998;32(2):293-7. (Pubitemid 28376487)
59. De Bruyne MC, Kors JA, Hoes AW, Klootwijk P, Dekker JM, Hofman A, van Bemmel JH, Grobbee DE. Both decreased and increased heart rate variability on the standard 10-second electrocardiogram predict cardiac mortality in the elderly: the Rotterdam Study. Am J Epidemiol. 1999;150(12):1282-8.
60. Tsuji H, Venditti FJ Jr, Manders ES, Evans JC, Larson MG, Feldman CL, Levy D. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation. 1994;90(2):878-83. (Pubitemid 24242758)
61. Mølgaard H, Sørensen KE, Bjerregaard P. Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death. Clin Auton Res. 1991;1(3):233-7.
62. Tsuji H, Larson MG, Venditti FJ Jr, Manders ES, Evans JC, Feldman CL, Levy D. Impact of reduced heart rate variability on risk for cardiac events. The Framingham Heart Study. Circulation. 1996;94(11):2850-5. (Pubitemid 26411751)
63. Facchini M, Malfatto G, Sala L, Silvestri G, Fontana P, Lafortuna C, Sartorio A. Changes of autonomic cardiac profile after a 3-week integrated body weight reduction program in severely obese patients. J Endocrinol Invest. 2003;26(2):138-42. (Pubitemid 36503061)
64. Karason K, Mølgaard H, Wikstrand J, Sjöström L. Heart rate variability in obesity and the effect of weight loss. Am J Cardiol. 1999;83(8):1242-7. (Pubitemid 29183925)
65. Lishner M, Akselrod S, Avi VM, Oz O, Divon M, Ravid M. Spectral analysis of heart rate fluctuations. A non-invasive, sensitive method for the early diagnosis of autonomic neuropathy in diabetes mellitus. J Auton Nerv Syst. 1987;19(2):119-25. (Pubitemid 17068484)
66. Massin MM, Derkenne B, Tallsund M, Rocour-Brumioul D, Ernould C, Lebrethon MC, Bourguignon JP. Cardiac autonomic dysfunction in diabetic children. Diabetes Care. 1999;22(11):1845-50. (Pubitemid 29521872)
67. Melanson EL, Freedson PS. The effect of endurance training on resting heart rate variability in sedentary adult males. Eur J Appl Physiol. 2001;85(5):442-9. (Pubitemid 32894562)
68. Sharpey-Schafer EP, Taylor PJ. Absent circulatory reflexes in diabetic neuritis. Lancet. 1960;1(7124):559-62.
69. Rydén L, Standl E, Bartnik M, Van den Berghe G, Betteridge J, de Boer MJ, Cosentino F, Jönsson B, Laakso M, Malmberg K, Priori S, Ostergren J, Tuomilehto J, Thrainsdottir I, Vanhorebeek I, Stramba-Badiale M, Lindgren P, Qiao Q, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Deckers JW, Bertrand M, Charbonnel B, Erdmann E, Ferrannini E, Flyvbjerg A, Gohlke H, Juanatey JR, Graham I, Monteiro PF, Parhofer K, Pyörälä K, Raz I, Schernthaner G, Volpe M, Wood D; Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J. 2007;28(1):88-136. (Pubitemid 46137814)
70. Pavy-Le Traon A, Fontaine S, Tap G, Guidolin B, Senard JM, Hanaire H. Cardiovascular autonomic neuropathy and other complications in type 1 diabetes. Clin Auton Res. 2010;20(3):153-60. Epub 2010 Mar 31.
71. Istenes I, Keresztes K, Hermányi Z, Putz Z, Vargha P, Gandhi R, Tesfaye S, Kempler P. Relationship between autonomic neuropathy and hypertension - are we underestimating the problem? Diabet Med. 2008;25(7):863-6.
72. Ko SH, Song KH, Park SA, Kim SR, Cha BY, Son HY, Moon KW, Yoo KD, Park YM, Cho JH, Yoon KH, Ahn YB. Cardiovascular autonomic dysfunction predicts acute ischaemic stroke in patients with Type 2 diabetes mellitus: a 7-year follow-up study. Diabet Med. 2008;25(10):1171-7.
73. Houssay S, Alvariñas JH, Burlando G, Gonzalez C, Garcia A, Vasta S. The relation of heart rate variability with glycemic variability in type 1 diabetic patients (Abstract 658-P). Acute and Chronic Complications Diabetes July 2011 60:A133-A195; doi:10.2337/db11-478-715.
74. Skladnev VN, Tarnavskii S, McGregor T, Ghevondian N, Gourlay S, Jones TW. Hypoglycemia alarm enhancement using data fusion. J Diabetes Sci Technol. 2010;4(1):34-40.
75. Skladnev VN, Ghevondian N, Tarnavskii S, Paramalingam N, Jones TW. Clinical evaluation of a noninvasive alarm system for nocturnal hypoglycemia. J Diabetes Sci Technol. 2010;4(1):67-74.
76. Pedersen O, Gaede P. Intensified multifactorial intervention and cardiovascular outcome in type 2 diabetes: the Steno-2 study. Metabolism. 2003;52(8 Suppl 1):19-23. (Pubitemid 37098385)
77. Hoogwerf BJ, Young JB. The HOPE study. Ramipril lowered cardiovascular risk, but vitamin E did not. Cleve Clin J Med. 2000;67(4):287-93. (Pubitemid 30219953)
78. Kontopoulos AG, Athyros VG, Didangelos TP, Papageorgiou AA, Avramidis MJ, Mayroudi MC, Karamitsos DT. Effect of chronic quinapril administration on heart rate variability in patients with diabetic autonomic neuropathy. Diabetes Care. 1997;20(3):355-61. (Pubitemid 27098224)
79. Gerritsen J, Dekker JM, TenVoorde BJ, Kostense PJ, Heine RJ, Bouter LM, Heethaar RM, Stehouwer CD. Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. Diabetes Care. 2001;24(10):1793-8. (Pubitemid 33716484)
80. Boulton AJ, Vinik AI, Arezzo JC, Bril V, Feldman EL, Freeman R, Malik RA, Maser RE, Sosenko JM, Ziegler D; American Diabetes Association. Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care. 2005;28(4):956-62. (Pubitemid 40434506)
81. Liang C, Doherty JU, Faillace R, Maekawa K, Arnold S, Gavras H, Hood WB Jr. Insulin infusion in conscious dogs. Effects on systemic and coronary hemodynamics, regional blood flows, and plasma catecholamines. J Clin Invest. 1982;69(6):1321-36. (Pubitemid 12081060)
82. Page MM, Watkins PJ. Provocation of postural hypotension by insulin in diabetic autonomic neuropathy. Diabetes. 1976;25(2):90-5.
83. Page MM, Smith RB, Watkins PJ. Cardiovascular effects of insulin. Br Med J. 1976;1(6007):430-2.
84. Kildegaard J, Christensen TF, Hejlesen OK. Sources of glycemic variability - what type of technology is needed? J Diabetes Sci Technol. 2009;3(4):986-91.
85. Waldron-Lynch F, Herold KC. Continuous glucose monitoring: long live the revolution! Nat Clin Pract Endocrinol Metab. 2009;5(2):82-3. Epub 2008 Dec 17.
86. Boyne MS, Silver DM, Kaplan J, Saudek CD. Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor. Diabetes. 2003;52(11):2790-4. (Pubitemid 37339709)
87. Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care. 2005;28(5):1231-9. (Pubitemid 40616646)